Something wrong? Let us know
Checked
Federal dataHealth
Golimumab
Published by U.S. Food and Drug Administration · Updated 03/17/2025 · Yearly
- Last updated
- 03/17/2025
- First published 09/16/2016
- Update frequency
- Yearly
- Formats
- Web only
- Coverage
- Nationwide
- Federal data
About this dataset
Simponi (golimumab) is a prescription medication manufactured by Janssen Biotech, Inc., used as a tumor necrosis factor (TNF) blocker to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It comes as a subcutaneous injection in prefilled syringes containing 100 mg/mL solution. This information was generated using AI and is provided for informational and research purposes only.
Files and access
Links open the official government source
- Golimumabaccessdata.fda.govWeb page
Links open outside websites we do not control.
Frequently asked questions
- Who publishes Golimumab?
- U.S. Food and Drug Administration, part of U.S. Department of Health & Human Services, publishes this dataset on Data.gov.
- How often is it updated?
- The publisher lists the update frequency as yearly. The last update was on 03/17/2025.
- How do I download it?
- Use the official source link above to view or request the data.
Similar data from other publishers
- GolimumabState of VirginiaSimponi (golimumab) is a prescription medication manufactured by Janssen Biotech, Inc., used as a tumor necrosis factor (TNF) blocker to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It comes as a subUpdated 09/29/2026
- GolimumabState of VirginiaSimponi (golimumab) is a prescription medication manufactured by Janssen Biotech, Inc., used as a tumor necrosis factor (TNF) blocker to treat inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It comes as a subUpdated 07/06/2026
- BelimumabState of VirginiaBenlysta (belimumab) is a prescription medication from GlaxoSmithKline LLC, administered as a subcutaneous injection to inhibit B lymphocyte activation, helping manage autoimmune conditions like lupus. It comes in 200 mg/mL strength in prefilled syringes. ThisUpdated 03/24/2026
- Adalimumab-attoState of VirginiaAMJEVITA (adalimumab-atto) is a biosimilar medication to Humira, containing the active ingredient adalimumab, a monoclonal antibody that blocks tumor necrosis factor (TNF) to reduce inflammation. It's administered via subcutaneous injection in strengths like 2Updated 09/29/2026
- Adalimumab-aqvhState of VirginiaYUSIMRY (adalimumab-aqvh) is a prescription biologic drug that blocks tumor necrosis factor, a protein involved in inflammation. It's a monoclonal antibody used to treat autoimmune conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel diseaseUpdated 03/24/2026
Where this catalog comes from
- Data.gov CatalogU.S. General Services Administration
- State and local open data portalsSocrata Discovery API
- State and city CKAN portalsCalifornia, Virginia, Boston, Houston and more
- Government ArcGIS Hub sitesCity and county GIS data
Catalog checked 10/24/2026
We list dataset descriptions only. Downloads and APIs link straight to the official government source, which holds the current version and its terms of use.
Source: Data.gov · Last updated 10/24/2026 · Listing only; the data stays with the publisher
Share: